|Follow us :|
Luai Al Bakour
El Temamy Pharmacy
Akoni Hijyen Teknolojileri Sanayi ve Dış Ticaret LTD. ŞTİ
Britton Chance Center for Biomedical Photonics
Arabian Trade Center - ATC
Medical Facility (32206):
Legality International. (Pvt.) Ltd.
MainYou must sign in to use this servcie
Feedback - Please use the form below to send your query or comment
You must sign in to use this servcie
Acute bacterial otitis media ( Rocephin ); treatment of infections of lower respiratory tract, skin and skin structures, bone and joint, and urinary tract; treatment of pelvic inflammatory disease, intra-abdominal infections, gonorrhea ( Rocephin ), meningitis, and septicemia caused by susceptible microorganisms; preoperative prophylaxis. Unlabeled Uses Neurologic complications, arthritis, and carditis associated with Lyme disease in patients refractory to penicillin G.
Hypersensitivity to cephalosporins; neonates (28 days of age or younger); concomitant use with calcium-containing IV solutions, including continuous calcium-containing infusions, such as parenteral nutrition in neonates.
GI Diarrhea (2%). Hematologic-Lymphatic Eosinophilia (6%); thrombocytosis (5%); leukopenia (2%). Lab Tests Elevated ALT and AST (3%); elevated BUN (1%). Local Induration/tightness/warmth (17%); induration/pain/tenderness (1%). Miscellaneous Fatal ceftriaxone-calcium precipitates in lung and kidneys of neonates.
Aminoglycosides Increased risk of nephrotoxicity. Anticoagulants (eg, heparin, warfarin) Risk of bleeding may be increased. Cyclosporine Elevated cyclosporine levels with increased risk of toxicity may occur. Incompatibility Other antimicrobial drugs. Laboratory Test Interactions None well documented.
Monitor Periodically measure plasma levels of the drug in patients with impaired renal function. If evidence of drug accumulation is present, adjust the dose accordingly. In patients with both hepatic function impairment and renal disease, closely monitor ceftriaxone plasma concentrations. Monitor PT in patients with impaired vitamin K synthesis or low vitamin K stores. Adverse reactions Monitor patient for GI, skin, and general body adverse reactions and signs of superinfection. Instruct patient to inform health care provider if noted and significant, and to immediately report severe diarrhea, diarrhea containing blood or pus, or severe abdominal cramping. Response to therapy Monitor patient’s response to therapy. Pregnancy Category B . Lactation Excreted in breast milk. Children Cephalosporins may accumulate in newborns. Hypersensitivity Reactions range from mild to life-threatening. Administer drug with caution to penicillin-sensitive patients because of possible cross-reactivity. Renal Function No dosage adjustment is needed in patients with renal failure who are receiving usual doses of ceftriaxone. Hepatic Function No dosage adjustment is needed in patients with hepatic function impairment; however, in patients with both hepatic function impairment and renal disease, the dosage should not exceed 2 g daily without close monitoring of serum concentrations. Superinfection May result in bacterial or fungal overgrowth of nonsusceptible microorganisms. Calcium-containing products Because of the possibility of precipitation of ceftriaxone calcium, do not administer ceftriaxone and a calcium-containing IV solution simultaneously. In patients other than neonates, ceftriaxone and calcium-containing solutions may be administered sequentially if the infusion lines are flushed with a compatible fluid between infusions. Prothrombin time Alterations in PT may occur. Pseudomembranous colitis Consider in patients in whom diarrhea develops. Sonographic abnormalities Sonographic abnormalities in the gallbladder, with symptoms of gallbladder disease, have been reported.
SOLUTION FOR INJECTION
Dosage and AdministrationYou must sign in to use this servcie
Technical DescriptionYou must sign in to use this servcie
Samir Moussa M.D.
Dr. Samer Al-Jneidy
Dr. Hani Najjar
Dr. Talal Sabouni
Dr. Faisal Dibsi
Dr. Tahsin Martini
Dr . Dirar Abboud
Yaser Habrawi , F.R.C.S.Ed